COVID-19 vaccine hesitancy and related factors among primary healthcare workers in a district of Istanbul: a cross-sectional study from Turkey.


Journal

Family medicine and community health
ISSN: 2009-8774
Titre abrégé: Fam Med Community Health
Pays: England
ID NLM: 101700650

Informations de publication

Date de publication:
04 2022
Historique:
entrez: 26 4 2022
pubmed: 27 4 2022
medline: 28 4 2022
Statut: ppublish

Résumé

This study aimed to determine the COVID-19 risk perceptions, vaccination intentions and predictive factors of family physicians and family healthcare staff working in primary care in Üsküdar. A cross-sectional study was performed using an online questionnaire to determine the demographic and general characteristics of the participants and their willingness to be vaccinated. An online questionnaire was applied to family physicians and family health workers working in primary care family health centres in Üsküdar between 25 and 29 December 2020. Multivariate analysis was performed to identify independent predictors of the willingness of individuals to be vaccinated. Out of 323 health workers working in 44 family health centres in the district, a total of 276 health workers were reached, including 126 physicians (n=158, 79.7%) and 150 midwives/nurses (n=165, 90.9%) (response rate 85.4%). 50.4% (n=139) of the healthcare workers were willing to have the COVID-19 vaccine, 29% (n=80) were undecided and 20.7% (n=57) refused the vaccine. The rate of acceptance to be vaccinated was higher in physicians, in men and in those who had not received a seasonal influenza vaccination regularly each year. Half of the primary healthcare workers, one of the high-risk groups in the pandemic, were hesitant or refused to be vaccinated for COVID-19. Knowing the factors affecting the vaccine acceptance rates of healthcare professionals can be considered one of the most strategic moves in reaching the target of high community vaccination rates. For evidence-based planning in vaccination studies, there is a need to investigate the reasons for COVID-19 vaccine acceptance by healthcare workers at all levels.

Identifiants

pubmed: 35470223
pii: fmch-2021-001430
doi: 10.1136/fmch-2021-001430
pmc: PMC9039154
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0
Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

EBioMedicine. 2015 Jun 23;2(8):891-7
pubmed: 26425696
BMC Fam Pract. 2020 Jul 28;21(1):151
pubmed: 32718313
Lancet. 2020 Mar 21;395(10228):931-934
pubmed: 32164834
Int J Clin Pract. 2021 Aug;75(8):e14336
pubmed: 33973322
BMJ. 2020 Oct 28;371:m4113
pubmed: 33115704
Health Educ Behav. 2019 Jun;46(3):445-453
pubmed: 30616381
J Hosp Infect. 2021 Feb;108:168-173
pubmed: 33259883
Clin Microbiol Infect. 2018 Aug;24(8):858-864
pubmed: 29104170
BMC Infect Dis. 2021 Aug 5;21(1):762
pubmed: 34353279
Postgrad Med J. 2023 Jun 15;99(1172):520-528
pubmed: 37319159
Hum Vaccin Immunother. 2021 Oct 3;17(10):3377-3383
pubmed: 34142925
PLoS One. 2019 Oct 31;14(10):e0224330
pubmed: 31671115
Eur J Epidemiol. 2020 Aug;35(8):775-779
pubmed: 32785815
Vaccine. 2017 Oct 27;35(45):6059-6069
pubmed: 28974409
Int J Clin Pract. 2021 Jul;75(7):e14226
pubmed: 33864328
Fam Med Community Health. 2021 Nov;9(4):
pubmed: 34740897
Soc Sci Med. 2021 Mar;272:113688
pubmed: 33485215
Vaccine. 2020 Oct 21;38(45):7049-7056
pubmed: 32980199
Front Med (Lausanne). 2020 Jun 23;7:348
pubmed: 32671082
Vaccine. 2016 Dec 20;34(52):6700-6706
pubmed: 27810314
Clin Microbiol Infect. 2018 Aug;24(8):799-800
pubmed: 29649595
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
Euro Surveill. 2021 Jan;26(3):
pubmed: 33478623
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
Vaccine. 2021 Jan 22;39(4):738-745
pubmed: 33386176
Vaccines (Basel). 2021 Jul 01;9(7):
pubmed: 34358132
Am J Infect Control. 2021 Sep;49(9):1152-1157
pubmed: 33930516
J Public Health (Oxf). 2016 Dec 02;38(4):746-753
pubmed: 28158550
Vaccine. 2018 Jan 25;36(4):545-552
pubmed: 29233605
Vaccine. 2010 Aug 9;28(35):5703-10
pubmed: 20600497

Auteurs

Hatice İkiışık (H)

Department of Public Health, Istanbul Medeniyet University Faculty of Medicine, Uskudar, Istanbul, Turkey, Üsküdar, Istanbul, Turkey drhatice.ikiisik@gmail.com.

Mehmet Akif Sezerol (MA)

Public Health Department, Institute of Health Sciences, Istanbul University, Istanbul University, Fatih, Istanbul, Turkey.

Yusuf Taşçı (Y)

Public Health Department, Institute of Health Sciences, Istanbul University, Istanbul University, Fatih, Istanbul, Turkey.

Işıl Maral (I)

Department of Public Health, Istanbul Medeniyet University Faculty of Medicine, Uskudar, Istanbul, Turkey, Üsküdar, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH